Age-Specific Outcomes of Bioprosthetic vs. Mechanical Aortic Valve Replacement: Balancing Reoperation Risk with Anticoagulation Burden.
Fatimah A AlhijabLatifa A AlfayezEssam HassanMonirah A AlbabtainIsmail M ElnaggarKhaled A AlotaibiAdam I AdamClaudio PragliolaHuda H IsmailAmr A ArafatPublished in: Journal of cardiovascular development and disease (2024)
The outcomes of mechanical and bioprosthetic valve replacement were comparable in patients older than 50 years. Using bioprosthetic valves in patients younger than 50 years was associated with a greater rate of valve reintervention, with no beneficial effect on the risk of bleeding or stroke.
Keyphrases
- aortic valve replacement
- aortic valve
- aortic stenosis
- ejection fraction
- mitral valve
- transcatheter aortic valve implantation
- end stage renal disease
- transcatheter aortic valve replacement
- atrial fibrillation
- newly diagnosed
- chronic kidney disease
- prognostic factors
- type diabetes
- left ventricular
- venous thromboembolism
- metabolic syndrome
- skeletal muscle
- patient reported
- insulin resistance
- glycemic control
- middle aged